Last updated on September 11th, 2021 at 08:00 am
Moroccan authorities decided on Wednesday to impose a night curfew during the holy month of Ramadan because of the recent rise in cases of COVID-19, with scientists announcing the discovery of a new local strain of the virus. The curfew comes during Ramadan, the Muslim holy month of Ramadan.
Many Moroccans have voiced their decision on social media, describing it as another setback for many businesses that are already struggling to survive, as well as family gatherings that are central to the holiday.
According to sources, the government has asked the council to issue a fatwa to stop Tarawih prayers, given the recent changes in the epidemic. The council is expected to issue a final decision soon.
However, reports indicate that it is now evening prayers mosque ban again this year to prevent the spread of Covid looga-19. Morocco is on a par with the epidemic in 19 other parts of the continent and is at a critical juncture in the spread of the disease. Moroccan Prime Minister Saad-Eddine El Othmani has previously said that the situation of the epidemic in Morocco has seen new alarming developments, including an increase in the number of new cases of ‘Covid-19’, an increase in the number of serious cases as well as “the challenge of getting new vaccines.”
READMORE: Mass Protests Against Farmajo’s Extension In Shirkule Village-Mogadishu
Countries around the Mideast imposed virus and curfew restrictions during Ramadan last year, and many are considering, or updating, restrictions this year. Morocco reported more than 499,000 DISEASES-19 infections and 8,865 deaths.
The kingdom has received the largest vaccination in Africa so far – 8.3 million doses for a population of 36 million since the vaccine began in Jan. 29. Vaccination per capita is higher than in some European countries starting a month ago, but concerns are growing that Moroccan vaccine supplies are drying up and prices could fall.
Morocco uses AstraZeneca and China Sinopharm vaccines. Millions more doses are expected from both companies as well as the international COVAX program to provide vaccinations in low- and middle-income countries.
